OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES

<p>For today there are convincing evidences of beneficial effect of ω-3 polyunsaturated fatty acids (PUFA) - eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids – in a number of cardiovascular diseases. Efficacy of ω-3 PUFA was confirmed by results of the large-scale clinical trials. Data o...

Full description

Bibliographic Details
Main Authors: A. V. Govorin, A. P. Filev
Format: Article
Language:English
Published: Столичная издательская компания 2015-12-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:http://www.rpcardio.ru/jour/article/view/422
_version_ 1827846473667051520
author A. V. Govorin
A. P. Filev
author_facet A. V. Govorin
A. P. Filev
author_sort A. V. Govorin
collection DOAJ
description <p>For today there are convincing evidences of beneficial effect of ω-3 polyunsaturated fatty acids (PUFA) - eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids – in a number of cardiovascular diseases. Efficacy of ω-3 PUFA was confirmed by results of the large-scale clinical trials. Data on ω-3 PUFA efficacy in heart failure and cardiac arrhythmia were received, besides their well-known hypolipidemic effect. Low level of ω-3 PUFA biomarker , ω-3 index (content of EPA and DHA in erythrocytes), is considered as a risk factor of coronary heart disease as well as a risk factor of fatal arrhythmias. Use of standardized medicinal product with high content of EPA and DHA leads to the positive therapeutic effect in patients with different cardiovascular diseases.</p>
first_indexed 2024-03-12T09:14:17Z
format Article
id doaj.art-e0a475bdfdfe429a91a5b4aa4a2c9f0a
institution Directory Open Access Journal
issn 1819-6446
2225-3653
language English
last_indexed 2024-03-12T09:14:17Z
publishDate 2015-12-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj.art-e0a475bdfdfe429a91a5b4aa4a2c9f0a2023-09-02T14:52:01ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-12-01819510210.1234/1819-6446-2012-1-95-102422OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASESA. V. Govorin0A. P. Filev1Читинская медицинская академияЧитинская медицинская академия<p>For today there are convincing evidences of beneficial effect of ω-3 polyunsaturated fatty acids (PUFA) - eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids – in a number of cardiovascular diseases. Efficacy of ω-3 PUFA was confirmed by results of the large-scale clinical trials. Data on ω-3 PUFA efficacy in heart failure and cardiac arrhythmia were received, besides their well-known hypolipidemic effect. Low level of ω-3 PUFA biomarker , ω-3 index (content of EPA and DHA in erythrocytes), is considered as a risk factor of coronary heart disease as well as a risk factor of fatal arrhythmias. Use of standardized medicinal product with high content of EPA and DHA leads to the positive therapeutic effect in patients with different cardiovascular diseases.</p>http://www.rpcardio.ru/jour/article/view/422ω-3 полиненасыщенные жирные кислотысердечная недостаточностьнарушения ритма
spellingShingle A. V. Govorin
A. P. Filev
OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES
Рациональная фармакотерапия в кардиологии
ω-3 полиненасыщенные жирные кислоты
сердечная недостаточность
нарушения ритма
title OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES
title_full OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES
title_fullStr OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES
title_full_unstemmed OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES
title_short OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES
title_sort omega 3 polyunsaturated fatty acids in the treatment of patients with cardiovascular diseases
topic ω-3 полиненасыщенные жирные кислоты
сердечная недостаточность
нарушения ритма
url http://www.rpcardio.ru/jour/article/view/422
work_keys_str_mv AT avgovorin omega3polyunsaturatedfattyacidsinthetreatmentofpatientswithcardiovasculardiseases
AT apfilev omega3polyunsaturatedfattyacidsinthetreatmentofpatientswithcardiovasculardiseases